The pleural space is a thin cavity between the two layers of the pleura, which is a membrane that lines the chest wall and lungs. It is filled with a small amount of fluid that helps lubricate the space and enable the lungs to move easily within the chest cavity. When this space becomes filled with an abnormal amount of fluid, it is known as pleural effusion. This condition can be caused by a variety of factors, including infection, tumors, heart failure, and autoimmune diseases. In this article, we will explore the various causes of pleural effusion and how they can be diagnosed and treated.
Pleural effusion is an accumulation of fluid in the pleural space, which can cause discomfort and breathing difficulty. This fluid can be either transudate, which is a non-inflammatory fluid, or exudate, which is an inflammatory fluid. The cause of the effusion can be determined by analyzing the fluid. Common causes of pleural effusion include infection, heart failure, malignancy, and autoimmune diseases.
Infection is one of the most common causes of pleural effusion, particularly in children. The most common causes of infection-related pleural effusion are pneumonia, tuberculosis, and other respiratory viruses. In some cases, the infection can spread to the pleural space and cause an accumulation of fluid.
Another common cause of pleural effusion is heart failure. When the heart is unable to pump enough blood around the body, it can cause fluid to back up in the lungs and pleural space. This can lead to an accumulation of fluid in the pleural space, resulting in pleural effusion.
Malignancy, or cancer, can also cause pleural effusion. Cancer cells can spread to the pleural space and cause an accumulation of fluid. This can be seen in lung cancer, mesothelioma, and other types of cancer.
Autoimmune diseases, such as rheumatoid arthritis, lupus, and scleroderma, can also cause pleural effusion. In these cases, the body’s immune system attacks the pleural space, resulting in an accumulation of fluid.
Pleural effusion is typically diagnosed through imaging tests, such as chest X-rays or CT scans. Once the effusion has been confirmed, the cause must be determined. This can be done through a variety of tests, including a pleural fluid analysis, a pleural biopsy, or a thoracentesis. Once the cause of the effusion has been determined, treatment can begin. Treatment will vary depending on the cause of the effusion, but may include antibiotics for infection, diuretics for heart failure, chemotherapy for cancer, or immunosuppressive drugs for autoimmune diseases.
Pleural effusion is an accumulation of fluid in the pleural space. It can be caused by a variety of factors, including infection, heart failure, malignancy, and autoimmune diseases. Diagnosis is typically done through imaging tests, such as chest X-rays or CT scans, and treatment will vary depending on the cause. With proper diagnosis and treatment, pleural effusion can be managed and the patient’s quality of life can be improved.
1.
Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries
2.
Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC
3.
Hereditary cancer has a rare and underreported cause.
4.
New imaging guidelines for head and neck cancers, a step toward practice change
5.
BMTs that are "half-matched" are effective in treating severe sickle cell disease.
1.
Oncolytic Adenoviruses Targeting PD-L1: Advancing Cancer Immunotherapy and Tumor Control
2.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
3.
Essential Updates in Hematology in Daily Practice
4.
The Predictive Power of Theranostics in Palliative Neuroendocrine Tumor Management
5.
Importance of Early Detection in Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
5.
A New Era in Managing Cancer-Associated Thrombosis
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation